Lv7
5000 积分 2023-01-28 加入
Management of adverse events associated with TROP2-targeted antibody-drug conjugates in cancer patients
5天前
已关闭
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer
5天前
已完结
An Engineered Fc with a Single Glycosylation Site Enables the Precise Conjugation of an Antibody with One Payload
5天前
已完结
Interpretative Challenges in Animal Studies: Review of Case Studies and Implications for Toxicologic Pathology
8天前
已完结
Cancer Throughlines: 25 Years after First Approval, ADCs Continue to Pick up Steam
11天前
已关闭
Ocular Toxicity Associated With Mirvetuximab Soravtansine: Navigating Clinical Relevance and Divergent Regulatory Recommendations
11天前
已关闭
Valine-Alanine-Based Peptidomimetic Linker for Antibody-Drug Conjugates
11天前
已完结
Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What’s the Current Status?
11天前
已关闭
Multi-attribute methods in antibody-drug conjugate characterization and quality control: Opportunities, challenges, and regulatory outlook
11天前
已完结
Advances in LC–MS strategies for comprehensive characterization and quantification of antibody-drug conjugates in preclinical and clinical settings
18天前
已关闭
皖公网安备34019202002308
